CCM
CLPT icon

Conway Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Conway Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$964K Sell
105,975
-20,750
-16% -$262K 0.45% 25
2025
Q4 		$1.73M Sell
126,725
-19,700
-13% -$365K 0.74% 21
2025
Q3 		$3.19M Sell
146,425
-17,800
-11% -$210K 1.34% 14
2025
Q2 		$1.96M Sell
164,225
-47,100
-22% -$593K 0.88% 19
2025
Q1 		$2.51M Buy
211,325
+50,100
+31% +$779K 1.26% 18
2024
Q4 		$2.48M Buy
161,225
+19,725
+14% +$255K 1.1% 19
2024
Q3 		$1.59M Buy
+141,500
New +$1.35M 0.77% 22
2023
Q2 		– Sell
-51,875
Closed -$438K – 46
2023
Q1 		$438K Sell
51,875
-12,650
-20% -$111K 0.36% 31
2022
Q4 		$547K Sell
64,525
-49,200
-43% -$466K 0.55% 25
2022
Q3 		$1.18M Buy
113,725
+26,559
+30% +$350K 1.05% 18
2022
Q2 		$1.14M Buy
87,166
+44,925
+106% +$459K 1.02% 23
2022
Q1 		$440K Buy
42,241
+16,091
+62% +$146K 0.28% 37
2021
Q4 		$293K Sell
26,150
-75,600
-74% -$1.13M 0.17% 47
2021
Q3 		$1.81M Sell
101,750
-14,550
-13% -$273K 1.22% 17
2021
Q2 		$2.22M Buy
116,300
+31,075
+36% +$600K 1.52% 16
2021
Q1 		$1.8M Buy
85,225
+61,484
+259% +$1.32M 1.35% 16
2020
Q4 		$377K Buy
+23,741
New +$213K 0.28% 52

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Conway Capital Management's CLPT Position: Q1 2026 in Review

Conway Capital Management reduced its ClearPoint Neuro (CLPT) stake by 16% in Q1 2026, selling an estimated $262K and leaving 105,975 shares worth $964K. The position accounts for 0.45% of the portfolio, ranked #25.

Conway Capital Management first reported a position in CLPT in Q4 2020 and has held it in 17 quarters since. The position peaked at $3.19M in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Conway Capital Management held 105,975 shares of ClearPoint Neuro worth $964K as of Q1 2026.
  • Conway Capital Management sold 20,750 ClearPoint Neuro shares in Q1 2026, an estimated $262K.
  • ClearPoint Neuro made up 0.45% of Conway Capital Management's portfolio in Q1 2026, its #25 holding.
  • Conway Capital Management first reported a position in ClearPoint Neuro in Q4 2020 and has held it in 17 quarters since.
  • Conway Capital Management's ClearPoint Neuro position peaked at $3.19M in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Conway Capital Management's 13F filing for Q1 2026, filed 7 May 2026.